Some of these proteins have been reported to have potential clinical significance and key proteins, such as the receptor tyrosine-protein kinase erbB-2 (ERBB2) and breast cancer 1 and 2 early onset, may be used as potential diagnostic, prognostic or predictive biomarkers (5,6). The gene discussed is ERBB2; the disease is breast carcinoma.